University of Texas MD Anderson Cancer Center announces $2.5 billion 'Only Possible Here, Campaign to End Cancer' at event in ...

MD Anderson Cancer Center has publicly launched its largest fundraising effort ever — which has already received major ...

The University of Texas MD Anderson Cancer Center today launches its historic $2.5 billion comprehensive philanthropic campaign, Only Possible Here, The Campaign to End Cancer.

Cogent Biosciences' stock has soared after its lead asset, bezuclastinib plus sunitinib, outperformed sunitinib alone in a ...

AM EST Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025 Multiple abstracts and a corporate workshop highlight Idylla™’s growing role in oncology diagnostics Itasca, IL, United States ...

Cogent Biosciences, Inc. stock soars after bezuclastinib's strong Phase 3 results in GIST. Click for my updated look at COGT ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Investing.com -- Cogent Biosciences (NASDAQ:COGT) stock surged 120% after the company reported positive results from its Phase 3 PEAK trial testing bezuclastinib plus sunitinib in gastrointestinal ...

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

HOUSTON, Nov. 11, 2025 /PRNewswire/ — Salarius Pharmaceuticals, Inc. (“Salarius” or the “Company”) (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of ...

IMUNON Presents Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting – On November 7, 2025, the Company presented translational data from the Phase 2 OVATION 2 ...